StockNews.AI
IRTC
StockNews.AI
194 days

iRhythm Technologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

1. iRhythm will release Q4 2024 results on February 20, 2025. 2. The conference call is scheduled for 1:30 PM PT / 4:30 PM ET. 3. Investors can access the call on iRhythm's investor website. 4. iRhythm focuses on digital health solutions for disease detection and prevention.

+1.34%Current Return
VS
-1.01%S&P 500
$108.5502/06 04:08 PM EDTEvent Start

$11002/07 10:45 PM EDTLatest Updated
3m saved
Insight
Article

FAQ

Why Bullish?

The scheduled earnings release often triggers positive price movements, particularly for health tech stocks.

How important is it?

The announcement of financial results is critical for investor perception and stock valuation.

Why Short Term?

Earnings announcements typically influence stock prices immediately or within days.

Related Companies

February 06, 2025 16:05 ET  | Source: iRhythm SAN FRANCISCO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the fourth quarter and full year 2024 after the close of trading on Thursday, February 20, 2025. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may access a live and archived webcast of the conference call on the “Quarterly Results” section of the company’s investor website at investors.irhythmtech.com. About iRhythm Technologies, Inc. iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all. Investor Contact Stephanie Zhadkevich investors@irhythmtech.com Media Contact Kassandra Perryirhythm@highwirepr.com

Related News